3rd Quarter - Report

AMERICAN ASSOCIATION FOR JUSTICE for AMERICAN ASSOCIATION FOR JUSTICE

Firm
Client
Income
—
Expenses
$1,150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R.6245 (Saving High-Tech Innovators from Egregious Legal Disputes Act of 2012); to provide for the recovery of computer hardware and software patent litigation costs in cases where the court finds the claimant did not have a reasonable likelihood of succeeding, and for other purposes.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps. L. Richardson; Wass.-Schultz
LINDA APRIL LIPSEN —

Contacted: Food & Drug Administration (FDA); SENATE; Housing & Urban Development, Dept of (HUD); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6245 (112th)

Transportation TRA

Lobbying with regard to minimum insurance requirements for commercial motor vehicles. Lobbying with regard to preemption of state based causes of action. Lobbying with regard to disclosure under the Federal Motor Carrier's Compliance Safety and Accountabilty program. Lobbying with regard to limiting the disclosure of information by rail carriers related to safety management systems.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
LINDA APRIL LIPSEN —
SARAH ROONEY —
SUSAN STEINMAN —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Housing & Urban Development, Dept of (HUD); SENATE

Aviation/Airlines/Airports AVI

Lobbying with regard to insurance requirements for general aviation aircraft owners.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
LINDA APRIL LIPSEN —

Contacted: Housing & Urban Development, Dept of (HUD); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Health Issues HCR

S.1718/H.R.1063 (Strengthening Medicare And Repaying Taxpayers Act of 2011); to amend title XVIII of the Social Security Act with respect to the application of Medicare secondary payer rules for certain claims. Lobbying with regard to Medicare set-asides for claimant related medical expenses. H.R.5284 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act); to amend section 1862 of the Social Security Act with respect to the application of Medicare secondary payer rules to workers' compensation settlement agreements and Medicare set-asides under such agreements.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
KATE ILAHI DEGRAVELLES Leg.Asst.Rep. Melancon
JULIA DUNCAN —
LINDA APRIL LIPSEN —
JENNIE RASMUSSEN —
SARAH ROONEY —
SUSAN STEINMAN —

Contacted: Housing & Urban Development, Dept of (HUD); Food & Drug Administration (FDA); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1063 (112th), H.R. 5284 (112th), S. 1718 (112th)

Marine/Maritime/Boating/Fisheries MAR

Lobbying with regard to liability in civil actions arising from maritime incidents generally. H.R.2838/S.1665 (Coast Guard Authorization Act of 2012); specific interest in provisions that would limit the rights of foreign seamen, decrease wage penalities for seamen and otherwise limit abiltity to seek and enforce a maritime lein.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schult
KATE ILAHI DEGRAVELLES Leg. Asst. Rep. Melancon
JENNIE RASMUSSEN —
ELISABETH STEIN —
SUSAN STEINMAN —

Contacted: White House Office; Food & Drug Administration (FDA); Housing & Urban Development, Dept of (HUD); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1665 (112th), H.R. 2838 (112th)

Consumer Issues/Safety/Products CSP

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R.3356 (ADA Compliance for Customer Entry to Stores and Services); to amend the Americans with Disabilities Act of 1990 to impose notice and a compliance opportunity to be provided before commencement of a private civil action. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. S.3204/H.R.4367 (no short title); to amend the Electronic Fund Transfer Act to limit the fee disclosure requirement for an automatic teller machine to the screen of that machine. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
KATE ILAHI DEGRAVELLES Leg. Asst. Rep. Melancon
JULIA DUNCAN —
LINDA APRIL LIPSEN —
JENNIE RASMUSSEN —
SARAH ROONEY —
ELISABETH STEIN Couns.; Rep. H. Johnson; Cts & Comp. Subcomm.
SUSAN STEINMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Housing & Urban Development, Dept of (HUD); Food & Drug Administration (FDA); White House Office

Bills named: H.R. 1873 (112th), H.R. 4367 (112th), S. 3204 (112th), H.R. 4369 (112th), S. 987 (112th), H.R. 4384 (112th), S. 2295 (112th), H.R. 6351 (112th), S. 3076 (112th), H.R. 3356 (112th), S. 1946 (112th), H.R. 6065 (112th), H.R. 3646 (112th)

Government Issues GOV

S.623/H.R.592 (Sunshine in Litigation Act of 2011); relating to the use of protective orders, sealing of cases, and disclosure of discovery information in federal civil cases. H.R.966/S.533 (Lawsuit Abuse Reduction Act of 2011); to amend Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to the destruction of electronic litigation data and original documents used in civil cases involving housing disputes. Lobbying with regard to clarifying state and federal court jurisdiction in certain cases. H.R.2032 (no short title); to restrict the ability of residents of intermediate care facilities for the mentally retarded to join a class in causes of action by federally-funded entities involving such residents that could result in an agreement to move such a resident from that resident's facility. Lobbying with regard to limitations on the award of fees and other expenses under the Equal Access to Justice Act generally. H.R.4078 (Red Tape Reduction and Small Business Job Creation Act ); specific interest in Lummis amendment (H.AMDT.1468) requiring the tracking and reporting of all payments issued pursuant to the Equal Access to Justice Act. Lobbying with regard to federal judicial selection generally, not specific to any nominated candidate; except specific lobbying with regard to the nominations of William Kayatta, Brian Davis, Robert Bacharach and Paul Grimm. S.3523 (Innovative Design Protection Act of 2012); specific interest in Lee amendment to require the losing party to pay the winning party's legal fees in certain litigation.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
KATE ILAHI DEGRAVELLES Leg. Asst. Rep. Melancon
JULIA DUNCAN —
LINDA APRIL LIPSEN —
JENNIE RASMUSSEN —
SARAH ROONEY —
ELISABETH STEIN Couns.; Rep. H. Johnson; Cts & Comp. Subcomm.
SUSAN STEINMAN —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Housing & Urban Development, Dept of (HUD); SENATE; Food & Drug Administration (FDA)

Bills named: S. 533 (112th), S. 3523 (112th), H.R. 966 (112th), S. 623 (112th), H.R. 592 (112th), H.R. 4078 (112th), H.R. 2032 (112th)

Homeland Security HOM

S.3414 (Cybersecurity Act of 2012); specific interest in limitations of liability and preemption of state based causes of action. Lobbying with regard to limitations of liability and preemption of state based causes of action as it relates to cybersecurity proposals generally.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
JULIA DUNCAN —
LINDA APRIL LIPSEN —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Housing & Urban Development, Dept of (HUD); Food & Drug Administration (FDA)

Bills named: S. 3414 (112th)

Torts TOR

Lobbying with regard to medical malpractice reform proposals generally. H.R.5 (Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011); to set conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. S.2264/H.R.4345 (Domestic Fuels Protection Act); to provide liability protection for claims based on the design, manufacture, sale, offer for sale, introduction into commerce, or use of certain fuels and fuel additives. S.1884/H.R.3627 (School Access to Emergency Epinephrine Act); specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine.

LobbyistCovered position, as disclosed
JOHN ROBERT BOWMAN Chief of Staff; Reps L. Richardson; Wass.-Schultz
KATE ILAHI DEGRAVELLES Leg. Asst. Rep. Melancon
JULIA DUNCAN —
LINDA APRIL LIPSEN —
JENNIE RASMUSSEN —
SARAH ROONEY —
ELISABETH STEIN Couns.; Rep. H. Johnson; Cts & Comp. Subcomm.
SUSAN STEINMAN —

Contacted: SENATE; Food & Drug Administration (FDA); Housing & Urban Development, Dept of (HUD); White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 1884 (112th), H.R. 5 (112th), H.R. 3627 (112th), H.R. 4345 (112th), S. 2264 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.